Cyclosporine-induced hypertension: Evidence for maintained baroreflex circulatory control

Lucini, D., Milani, R. V., Ventura, H. O., Mehra, M. R., Messerli, F. H., Murgo, J. P., Regenstein, F., Copley, B., Malliani, A. and Pagani, M. (1997) Cyclosporine-induced hypertension: Evidence for maintained baroreflex circulatory control. Journal of Heart and Lung Transplantation, 16 6: 615-620.

Author Lucini, D.
Milani, R. V.
Ventura, H. O.
Mehra, M. R.
Messerli, F. H.
Murgo, J. P.
Regenstein, F.
Copley, B.
Malliani, A.
Pagani, M.
Title Cyclosporine-induced hypertension: Evidence for maintained baroreflex circulatory control
Journal name Journal of Heart and Lung Transplantation   Check publisher's open access policy
ISSN 1053-2498
Publication date 1997-06
Sub-type Article (original research)
Volume 16
Issue 6
Start page 615
End page 620
Total pages 6
Place of publication Philadelphia, PA, United States
Publisher Elsevier
Language eng
Formatted abstract
Background: The clinical use of cyclosporine as an immunosuppressive agent enhanced long-term survival in transplant recipients at the expense of a high incidence of induced hypertension. Altered neurovegetative (autonomic) cardiovascular control is suspected as a mechanism of this form of hypertension.

Methods: Spectral analysis of systolic arterial pressure and R- R interval variability (electrocardiographic recordings) were performed, and the index α of baroreflex gain was computed in four groups of subjects matched for age: 13 orthotopic heart transplant recipients; 13 solid organ transplant recipients; 13 patients with essential hypertension; and 18 control subjects with normal blood pressure. All but the control subjects were treated with similar dihydropyridine calcium entry blockers. Heart and solid organ transplant recipients also received cyclosporine.

Results: R-R variance was lowest in the heart transplant recipients. The spectral profile of R-R interval was suggestive of sympathetic predominance in the patients withhypertension, but not in the solid organ transplant recipients or the control subjects. Systolic blood pressure variability and low frequency component (a marker of sympathetic vasomotor modulation) were similar in the four groups. The index α was 1.8 ± 2.2 in heart transplant recipients, 11.7 ± 6.6 in solid organ transplant recipients, 7.3 ± 3.6 in patients with hypertension, and 13.5 ± 6.4 msec/mm Hg in control subjects (p = 0.0001).

Conclusions: These data indicate that (1) cyclosporine-induced hypertension in heart transplant recipients is associated with a loss of baroreflex function as a result of cardiac denervation-related uncoupling; (2) compared with patients with hypertension, organ transplant recipients with hypertension demonstrated a maintained baroreflex function as indicated by a lack of reduction of the index α; (3) baroreflex heart rate control in dihydropyridine-treated cyclosporine-induced hypertension is well maintained.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 14 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 14 Mar 2011, 09:50:14 EST